Connect Biopharma Holdings Ltd (NYSE: CNTB) — Healthcare · Share Price, Chart & Market Data
About: Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.51 (-0.40%)
CNTBConnect Biopharma Holdings Ltd
Loading watchlist status…
Trade CNTB now
Connect Biopharma Holdings Ltd share price
CNTB price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:39 am GMT+0
CNTB price performance
-2.713%
5D
-27.246%
1M
-0.397%
YTD
209.877%
1Y
CNTB price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:39 am GMT+0
CNTB details
CNTB Market Signals